Schedule a call

Loading...

Solutions

Solutions Overview Risk Reduction Liquidity Option Exercise Financing Lifetime Income Tax Savings

Funds

Funds Overview Eligible Companies Late-Stage Fund Mid-Stage Fund Charitable Fund Liquidity Fund

Partners

Private Companies Financial Advisors Referral Program

About us

Our Team Contact us Careers Press Testimonials

Learn

Knowledge Center Collective Insights Series FAQ How Collective Works Instantly value your Pre-IPO stock Liquidity Estimator Pre-IPO Exchange Fund

Legal

Terms of Use Privacy Policy Privacy Notices

Collective Linkedin Page Collective Twitter Page Collective Facebook Page

All loans issued by WebBank, Member FDIC. Interests in the Collective Exchange Fund are not FDIC insured and may lose value.© 2024 Collective Liquidity. All rights Reserved.

Home Eligible CompaniesPrime Medicine Stock

Prime Medicine stock

Prime Medicine Stock

HealthTech

Looking to sell Prime Medicine stock or options?

Schedule a call Or start with a free online valuation

Eligible for:

Charitable Exchange Fund

Founded: 2019Funding to Date: $316Mhttps://www.primemedicine.com

Prime Medicine is a developer of groundbreaking gene-editing technology solutions aimed at treating genetic disorders. The company's unique genome-editing method, known as prime editing, has the capacity to rewrite DNA sequences. This innovative technology empowers healthcare professionals to precisely modify targeted DNA sequences, thereby correcting mutations that cause diseases.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund